Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus

International Journal of Antimicrobial Agents

Volumn 40, Issue 2, 2012, Pages 103-107

  Wang, Jiun Ling ^a   Tang, Hung Jen ^b   Hsieh, Pang Hsin ^c   Chiu, Fang Yao ^d   Chen, Yen Hsu ^e,f   Chang, Ming Chau ^d   Huang, Ching Tai ^g   Liu, Chang Pan ^h   Lau, Yeu Jun ⁱ   Hwang, Kao Pin ^j   Ko, Wen Chien ^k   Wang, Chen Ti ^l   Liu, Cheng Yi ^m   Liu, Chien Lin ^d   Hsueh, Po Ren ^l  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^g CHANG GUNG UNIVERSITY   (Taiwan)

^h MACKAY MEMORIAL HOSPITAL   (Taiwan)

ⁱ SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^j CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^k NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^l NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^m TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

more..

Author keywords

Bone and joint infection; Combination therapy; Fusidic acid; Meticillin resistant Staphylococcus aureus (MRSA); Rifampicin

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; FOSFOMYCIN; FUSIDATE SODIUM; FUSIDIC ACID; GLYCOPEPTIDE; LINEZOLID; MINOCYCLINE; PRISTINAMYCIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ASIA; BACTERIAL ARTHRITIS; BONE AND JOINT INFECTIONS; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENTIATION; DRUG TREATMENT FAILURE; ENDOCARDITIS; EUROPE; HUMAN; IN VITRO STUDY; INFECTIOUS ARTHRITIS; LOADING DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NORTH AMERICA; OSTEOMYELITIS; PRIORITY JOURNAL; PROSTHETIC JOINT INFECTION; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REVIEW; STAPHYLOCOCCUS INFECTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS INFECTION;

EID: 84864286748     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.03.010     Document Type: Short Survey

References (70)

1. P. Fernandes, and D. Pereira Efforts to support the development of fusidic acid in the United States Clin Infect Dis 52 Suppl. 7 2011 S542 S546
2. B.T. Tsuji, O.O. Okusanya, J.B. Bulitta, A. Forrest, S.M. Bhavnani, and P.B. Fernandez Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead Clin Infect Dis 52 Suppl. 7 2011 S513 S519
3. J. Turnidge Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics Int J Antimicrob Agents 12 Suppl. 2 1999 S23 S34
4. P. Collignon, and J. Turnidge Fusidic acid in vitro activity Int J Antimicrob Agents 12 Suppl. 2 1999 S45 S58
5. D. Spelman Fusidic acid in skin and soft tissue infections Int J Antimicrob Agents 12 Suppl. 2 1999 S59 S66
6. B. Atkins, and T. Gottlieb Fusidic acid in bone and joint infections Int J Antimicrob Agents 12 Suppl. 2 1999 S79 S93
7. M. Whitby Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus Int J Antimicrob Agents 12 Suppl. 2 1999 S67 S71
8. H. Schöfer, and L. Simonsen Fusidic acid in dermatology: an updated review Eur J Dermatol 20 2010 6 15
9. Australian Prescriber Rifampicin for MRSA. http://www. australianprescriber.com/magazine/33/5/145/6/ [accessed 02.04.12].
10. F.K. Gould, R. Brindle, P.R. Chadwick, A.P. Fraise, S. Hill, and D. Nathwani Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom J Antimicrob Chemother 63 2009 849 861
11. E.S. Darley, and A.P. MacGowan Antibiotic treatment of Gram-positive bone and joint infections J Antimicrob Chemother 53 2004 928 935
12. W. Zimmerli, A. Trampuz, and P.E. Ochsner Prosthetic-joint infections N Engl J Med 351 2004 1645 1654
13. A. Trampuz, and W. Zimmerli Prosthetic joint infections: update in diagnosis and treatment Swiss Med Wkly 135 2005 243 251
14. J.S. Davis Management of bone and joint infections due to Staphylococcus aureus Intern Med J 35 Suppl. 2 2005 S79 S96
15. P.C. Matthews, A.R. Berendt, M.A. McNally, and I. Byren Diagnosis and management of prosthetic joint infection BMJ 338 2009 b1773
16. N.M. Brown, D.S. Reeves, and C.M. McMullin The pharmacokinetics and protein-binding of fusidic acid in patients with severe renal failure requiring either haemodialysis or continuous ambulatory peritoneal dialysis J Antimicrob Chemother 39 1997 803 809
17. E. Somekh, T. Golan, A. Tanay, F. Poch, and M. Dan Concentration and bactericidal activity of fusidic acid and cloxacillin in serum and synovial fluid J Antimicrob Chemother 43 1999 593 596
18. M.A. Sattar, S.P. Barrett, and M.I. Cawley Concentrations of some antibiotics in synovial fluid after oral administration, with special reference to anti-staphylococcal activity Ann Rheum Dis 42 1983 67 74
19. J. Turnidge, and P. Collignon Resistance to fusidic acid Int J Antimicrob Agents 12 Suppl. 2 1999 S35 S44
20. M. Castanheira, A.A. Watters, J.M. Bell, J.D. Turnidge, and R.N. Jones Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008 Antimicrob Agents Chemother 54 2010 3614 3617
21. M.A. Pfaller, M. Castanheira, H.S. Sader, and R.N. Jones Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada Int J Antimicrob Agents 35 2010 282 287
22. M. Foldes, R. Munro, T.C. Sorrell, S. Shanker, and M. Toohey In vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus J Antimicrob Chemother 11 1983 21 26
23. B.F. Farber, Y.C. Yee, and A.W. Karchmer Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci Antimicrob Agents Chemother 30 1986 174 175
24. S.H. Zinner, H. Lagast, and J. Klastersky Antistaphylococcal activity of rifampin with other antibiotics J Infect Dis 144 1981 365 371
25. P.E. Varaldo, E. Debbia, and G.C. Schito In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species Antimicrob Agents Chemother 27 1985 615 618
26. D.J. Biedenbach, P.R. Rhomberg, R.E. Mendes, and R.N. Jones Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102) Diagn Microbiol Infect Dis 66 2010 301 307
27. O. Denis, C. Nonhoff, B. Byl, C. Knoop, S. Bobin-Dubreux, and M.J. Struelens Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features J Antimicrob Chemother 50 2002 383 391
28. A. Balkhair, Z. Al Muharrmi, L. Darwish, H. Farhan, and M. Sallam Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid Int J Infect Dis 14 Suppl. 3 2010 e227 e229
29. M.E. Falagas, K.G. Manta, F. Ntziora, and K.Z. Vardakas Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence J Antimicrob Chemother 58 2006 273 280
30. B.P. Howden, P.B. Ward, P.G. Charles, T.M. Korman, A. Fuller, and P. du Cros Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility Clin Infect Dis 38 2004 521 528
31. P. Grohs, M.D. Kitzis, and L. Gutmann In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus Antimicrob Agents Chemother 47 2003 418 420
32. R. Saginur, M. StDenis, W. Ferris, S.D. Aaron, F. Chan, and C. Lee Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections Antimicrob Agents Chemother 50 2006 55 61
33. X.H. Yu, X.J. Song, Y. Cai, B.B. Liang, D.F. Lin, and R. Wang In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus J Antibiot (Tokyo) 63 2010 657 659
34. H.J. Tang, C.C. Chen, K.C. Cheng, H.S. Toh, B.A. Su, and S.R. Chiang In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms J Antimicrob Chemother 67 2012 944 950
35. G. Cox, G.S. Thompson, H.T. Jenkins, F. Peske, A. Savelsbergh, and M.V. Rodnina Ribosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid Proc Natl Acad Sci USA 109 2012 2102 2107
36. D.J. Farrell, M. Castanheira, and I. Chopra Characterization of global patterns and the genetics of fusidic acid resistance Clin Infect Dis 52 Suppl. 7 2011 S487 S492
37. F.B. McLaws, A.R. Larsen, R.L. Skov, I. Chopra, and A.J. O'Neill Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 55 2011 1173 1176
38. O. Sule, N.M. Brown, L.J. Willocks, J. Day, S. Shankar, and C.R. Palmer Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use Int J Antimicrob Agents 30 2007 78 82
39. B.W. Mason, and A.J. Howard Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study Int J Antimicrob Agents 23 2004 300 303
40. M. Faber, and V.T. Rosdahl Susceptibility to fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption J Antimicrob Chemother 25 Suppl. B 1990 7 14
41. M. Castanheira, A.A. Watters, R.E. Mendes, D.J. Farrell, and R.N. Jones Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008) J Antimicrob Chemother 65 2010 1353 1358
42. A.J. O'Neill, F. McLaws, G. Kahlmeter, A.S. Henriksen, and I. Chopra Genetic basis of resistance to fusidic acid in staphylococci Antimicrob Agents Chemother 51 2007 1737 1740
43. A.J. O'Neill, A.R. Larsen, R. Skov, A.S. Henriksen, and I. Chopra Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus J Clin Microbiol 45 2007 1505 1510
44. A.J. O'Neill, A.R. Larsen, A.S. Henriksen, and I. Chopra A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates Antimicrob Agents Chemother 48 2004 3594 3597
45. F. Laurent, A. Tristan, M. Croze, M. Bes, H. Meugnier, and G. Lina Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France J Antimicrob Chemother 63 2009 420 421
46. G.D. Katopodis, I.N. Grivea, A.J. Tsantsaridou, S. Pournaras, E. Petinaki, and G.A. Syrogiannopoulos Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of central Greece BMC Infect Dis 10 2010 351
47. E.E. Udo, and E. Sarkhoo Genetic analysis of high-level mupirocin resistance in the ST80 clone of community-associated meticillin-resistant Staphylococcus aureus J Med Microbiol 59 2010 193 199
48. J.H. Song, P.R. Hsueh, D.R. Chung, K.S. Ko, C.I. Kang, and K.R. Peck Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study J Antimicrob Chemother 66 2011 1061 1069
49. K. Lee, H.S. Lee, S.J. Jang, A.J. Park, M.H. Lee, and W.K. Song Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and Gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone J Korean Med Sci 16 2001 262 270
50. H.B. Kim, H.C. Jang, H.J. Nam, Y.S. Lee, B.S. Kim, and W.B. Park In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey Antimicrob Agents Chemother 48 2004 1124 1127
51. E.E. Udo, N. Al-Sweih, E. Mokaddas, M. Johny, R. Dhar, and H.H. Gomaa Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004 BMC Infect Dis 6 2006 168
52. M.A. Alreshidi, and N.S. Mariana Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia Med J Malaysia 66 2011 276
53. L.Y. Hsu, T.H. Koh, K. Singh, M.L. Kang, A. Kurup, and B.H. Tan Dissemination of multisusceptible methicillin-resistant Staphylococcus aureus in Singapore J Clin Microbiol 43 2005 2923 2925
54. C.C. Lai, C.Y. Wang, C.C. Chu, C.K. Tan, C.L. Lu, and Y.L. Lee Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009 Eur J Clin Microbiol Infect Dis 30 2011 265 271
55. C.M. Chen, M. Huang, H.F. Chen, S.C. Ke, C.R. Li, and J.H. Wang Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital BMC Microbiol 11 2011 98
56. H.J. Chen, W.C. Hung, S.P. Tseng, J.C. Tsai, P.R. Hsueh, and L.J. Teng Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates Antimicrob Agents Chemother 54 2010 4985 4991
57. Y. Liu, W. Geng, Y. Yang, C. Wang, Y. Zheng, and Y. Shang Susceptibility and resistance determinants to fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections FEMS Immunol Med Microbiol 2011 10.1111/j.1574-695X.2011.00887.x [Epub ahead of print]
58. J. Ng, and I.B. Gosbell Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp. J Antimicrob Chemother 55 2005 1008 1012
59. A. Nather, V. David, H.T. Hee, and J. Thambiah Pyogenic vertebral osteomyelitis: a review of 14 cases J Orthop Surg (Hong Kong) 13 2005 240 244
60. H.L. Chiang, Y.Y. Chia, Y.S. Chen, C.C. Hung, K. Liu, and Y. Lo Epidural abscess in an obstetric patient with patient-controlled epidural analgesia - a case report Int J Obstet Anesth 14 2005 242 245
61. A.D. Donaldson, R.C. Chan, and I.B. Gosbell Community-acquired methicillin-resistant Staphylococcus aureus in bone and joint infections: development of rifampicin resistance Med J Aust 184 2006 196
62. D. Inverarity, J. Coia, G. O'Neill, and R. MacTier MRSA vertebral discitis managed successfully using linezolid as a component of an oral antibiotic regimen J R Coll Physicians Edinb 36 2006 112 114
63. C.A. Aboltins, M.A. Page, K.L. Buising, A.W. Jenney, J.R. Daffy, and P.F. Choong Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid Clin Microbiol Infect 13 2007 586 591
64. A. Apisarnthanarak, and L.M. Mundy Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin Int J Infect Dis 11 2007 283 284
65. R.J. Murray, J.C. Pearson, G.W. Coombs, J.P. Flexman, C.L. Golledge, and D.J. Speers Outbreak of invasive methicillin-resistant Staphylococcus aureus infection associated with acupuncture and joint injection Infect Control Hosp Epidemiol 29 2008 859 865
66. S. Ahamed Puthiyaveetil Osteomyelitis - a case report Aust Fam Physician 38 2009 521 523
67. T. Ferry, I. Uçkay, P. Vaudaux, P. François, J. Schrenzel, and S. Harbarth Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection Eur J Clin Microbiol Infect Dis 29 2010 171 180
68. B.J. O'Neill, K.M. Hirpara, and T.K. Kaar Successful treatment of chronic osteomyelitis of the radius ISRN Pediatrics 2011 1 2
69. E.R. Chiang, Y.P. Su, T.H. Chen, F.Y. Chiu, and W.M. Chen Comparison of articulating and static spacers regarding infection with resistant organisms in total knee arthroplasty Acta Orthop 82 2011 460 464
70. C.R. Wolfe Case report: treatment of chronic osteomyelitis Clin Infect Dis 52 Suppl. 7 2011 S538 S541